Polycom and AMD Global Telemedicine Inc. To Deliver Integrated Visual And Voice Telehealth Capability To Clinicians On-The-Go
Joint Polycom Converged Management Appliance (CMA) and AMD
ADEN™ Solution Offers laptop and desktop-based telehealth capabilities anywhere, anytime
North Chelmsford, MA (PRWEB) June 11, 2009 -- Polycom, Inc. [Nasdaq: PLCM, the global leader in telepresence, video,...
Positive Results for Ophthotech's Novel Therapy for Wet AMD - Study of Anti-PDGF and Anti-VEGF Therapy Shows Significant Neovascular Regression and Enhanced Visual Outcome
59% of patients showed 3-line gain (significant visual gain) and 100% neovascular regression
FORT LAUDERDALE, Fla., May 4 /PRNewswire/ -- Ophthotech Corp. today announced positive results of a phase 1 clinical study evaluating E10030, its novel anti-platelet derived growth factor (anti-PDGF...
EyeCare America Offers No-Cost Medical Eye Care to Qualified Seniors In Support of National AMD Month - March 2009
Age-related Macular Degeneration (AMD) is the leading cause of vision loss in people 65 years or older in the United States. According to the National Eye Institute, AMD
affects more than 10 million Americans.
San Francisco, CA -- Age-related Macular Degeneration (AMD)...
Texas Tech University Health Sciences Center and AMD Global Telemedicine Inc. Expand Telemedicine Program Throughout Texas AMD
Global Telemedicine Inc., supplies medical peripherals to the successful installations of 3 additional sites to expand Texas Tech University Health Sciences Center's advancing telemedicine program
N. Chelmsford, MA (PRWEB) January 30, 2009 -- For over 10 years, AMD...
Greenland's National Management of Health Partners with AMD Global Telemedicine Inc. and AFHCAN to Install Telemedicine Encounter Management Systems (TEMS) Across Greenland
Greenland to implement new Telemedicine Encounter Management Systems (TEMS) in an effort to provide more accessible, cost-effective health care.
N. Chelmsford, MA (PRWEB) December 15, 2008 -- Capitalizing on Tele-Greenland's infrastructure investment into Greenland by w...
FDA Grants NeoVista's Request to Utilize Novel Wet AMD Treatment in Compassionate Case
NeoVista's Epiretinal Brachytherapy Granted Compassionate Use to Attempt to Prevent Complete Vision Loss in Patient
FREMONT, Calif., Dec. 10 /PRNewswire/ -- NeoVista, Inc., announced today that the U.S. Food and Drug Administration (FDA) had approved the company's "compassionate cas...
NeoVista Presents Anatomic Outcomes of Novel Wet AMD Therapy at 2008 American Society of Retina Specialists Meeting
MAUI, Hawaii, Oct. 13 /PRNewswire/ -- NeoVista, Inc., presented
yesterday the anatomic effects of the company's novel epiretinal
brachytherapy device on choroidal neovascular lesions in an analysis at the
American Society of Retina Specialist's (ASRS) 26th Annual Meeting. The
12-month data pre...
Pilot Study to Assess Safety and Efficacy of Medidur(TM) FA in AMD Patients Treated With Lucentis(R)
ATLANTA, May 8 /PRNewswire/ -- Alimera Sciences Inc., a privately held
ophthalmic pharmaceutical company announced today that enrollment has begun
for a pilot study to assess the safety and efficacy of Medidur FA in
conjunction with Lucentis(R) (ranibizumab injection, Genentech) in patients
'Twinkle' eye test could improve AMD diagnosis
Scientists at UCL (University College London) have developed a more reliable test for detecting vision loss in people with age-related macular disease (AMD), the leading cause of blindness in the UK and US. The method, which centres on a visual illusion, could lead to earlier self-diagnosis of sig...
Limiting refined carbohydrates may stall AMD progression
Eating fewer refined carbohydrates may slow the progression of age-related macular degeneration (AMD), according to a new study from researchers at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University.
results in partial or total blindness in 7 to 15% of the eld...
AMD in Medical Technology
NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting
Long-Term Phase II Data Continue to Highlight Potential of NeoVista's Epiretinal Brachytherapy
SCOTTSDALE, Ariz., Sept. 29 /PRNewswire/ -- NeoVista, Inc. made public
yesterday 18-month data from the company's Phase II feasibility study
examining its novel epiretinal bra...
NeoVista Presents One Year Data on Novel Wet AMD Therapy at Macula Society
Data Analysis Shows Promise of Epiretinal Brachytherapy as NeoVista Progresses with Phase III CABERNET Study
PALM BEACH, Fla., March 28 /PRNewswire/ -- NeoVista, Inc. released
today to the eye community updated results from a one-year feasibility
study of the company's novel e...
NeoVista, Inc. Presents New Data on Its Novel Wet AMD Therapy at AAO
One-Year Data Provides Ophthalmologists Critical Insight on Novel Beta Radiation Epiretinal Therapy
NEW ORLEANS, Nov. 12 /PRNewswire/ -- NeoVista, Inc. revealed today new
data from a one-year feasibility study of the company's novel beta
radiation epiretinal therapy for t...
Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
-Groundbreaking Trial Is Designed to Compare Efficacy of Bevasiranib Administered Every 8 Weeks or 12 Weeks with Genentech's Lucentis(R) Administered Every 4 Weeks-
MIAMI, Aug. 30 /PRNewswire-FirstCall/ -- Opko Health Inc. (Amex: OPK )
today announced that the first pa...
VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--May 9, 2007 - Regeneron
Pharmaceuticals, Inc. (Nasdaq: REGN) today announced positive
results from several studies evaluating the VEGF Trap-Eye in the
neovascular form of age-related macular degeneration (wet AMD) and
diabetic macular edema (DME). These findi...
Lpath Demonstrates 'First-in-Class' AMD Results With Its Lead Drug
Sphingomab Shows Near-Complete Mitigation of Choroidal
Neovascularization (CNV) in an AMD
SAN DIEGO, May 22, 2007 /PRNewswire-FirstCall/ -- Lpath, Inc. ,
the category leader in therapeutic agents against bioactive lipids,
reported compelling proof-of-concept data in a standard animal
Potentia Pharmaceuticals' POT-4 Drug Candidate for Age-Related Macular Degeneration Successfully Completes Phase I Clinical Trial - Prepares for Phase II
...ffective against both dry and wet AMD.
is the leading cause of blindness in the elderly o...ted States alone. The current standard of care for amd
relies primarily on angiogenesis inhibitors, an ap...
Optherion Announces Issuance of Canadian Patents Covering Age-Related Macular Degeneration Diagnostics and Treatments
...nostic tests for determining the predisposition to amd
by screening for genetic modifications in several ...to healthcare professionals treating patients with amd
and other diseases of the alternative complement s...."
Optherion is developing a genetic test for amd
and is pursuing commercialization discussions with...
Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
...eovascular form of Age-related Macular Degeneration (wet AMD) and a Phase 2 study in patients with Diabetic Macular Edema (DME). Enrollment in the wet amd
and DME studies is expected to be completed later this year.
"Although CRVO is a leading cause of blindness, there is currently no treatment ava...
Tufts Medical Center Researchers Create a New Predictive Model for Age-related Macular Degeneration (AMD)
...s can predict progression to the advanced forms of amd
with a certainty as high as 83%. The paper, "Predi...ce.
Their research also shows that although amd
has a strong genetic component, healthy behaviors ... likelihood of progression to the advanced form of amd
increased from about three-fold for nonsmokers to ...
AMD in Medical Products
Now is a forum presenting interactive education on Age- related Macular Degeneration (AMD), amd
diagnosis and treatments, VEGF, aseptic technique and supportive care for p...
Description:... Macula Complete includes the nutrients used in the ARED study, as well as the Lutein Antioxidant Supplement Trial (LAST), which suggested no amd
disease progression in the study participants in a one year period. Macula Complete also contains efficacious amounts of nutrients suggested in peer-r...
PreView PHP (Preferential Hyperacuity Perimetry)
Description:...macular degeneration (AMD).
This macular perimeter maps and quantifies visual field defects consistent with the progression of intermediate ("dry") amd
to the wet stage of the disease. By overcoming the brain's ability to compensate for small visual field defects, the PreView PHP can identify choroida...
Company:Carl Zeiss Meditec, Inc.
Opal (PDT) Photoactivator
Description:... When it comes to laser treatment of amd
predominantly classic subfoveal choroidal neovascularization
(CNV), nothing compares to the Opal Photoactivator from
AMD in Medical Dictionary
...recipes, and more. Includes Weight Watchers point values for foods and restaurants. Articles featuring weight loss tips, diets, methods, amd
more. Which diet is right for you? eDiets.com offers a variety of plans for weight management, healthy living, fitness, recipes and support....
...ool of Medicine " Departments " Ophthalmology ... Monthly journal publishes review articles about eye disease. ... Injecting New Thinking into amd
Combination Therapy ... Subscribe to Review of Ophthalmology ... Ophthalmology was one of the foremost branches in medieval Islamic medicine. ...
AMD in Biological News
Omega-3 fatty acids appear to impact AMD progression
BOSTON (June 18, 2009) - Omega-3 fatty acids found in fatty fish such as tuna and salmon may protect against progression of age-related macular degeneration (AMD), but the benefits appear to depend on the stage of disease and whether certain supplements are taken, report researchers at the Laborat...
Major breakthrough in early detection and prevention of AMD
LEXINGTON, Ky. (June 15, 2009) A team of researchers led by Dr. Jayakrishna Ambati at the University of Kentucky has discovered a biological marker for neovascular age-related macular degeneration (AMD), the leading cause of blindness in older adults.
The marker, a receptor known as CCR3, show...
New supplement may help slow sight loss in elderly
...re companies Dr Mann Pharma and Bausch and Lomb.
is an incurable eye disease which causes blurring ...ate AMD.
When the eye disease progresses to late amd
patients are unable to read, watch television or r...geon at the Royal Hospital in Belfast, said: "Late amd
causes severe sight loss and has a huge economic i...
Diet could reduce onset of eye disease by 20 percent
...' form of the disease, which is suffered by 90% of amd
Professor Ian Grierson, Head of Opht...etables into everyday meals. The recipes will help amd
sufferers slow down the degeneration process by in...profound difference and can keep eye diseases like amd
at bay for up to 20% longer.
"There are of cou...
New open-source software permits faster desktop computer simulations of molecular motion
...package GROMACS that integrates the OpenMM library, enabling it to be sped up on high-end NVIDIA and AMD/ATI graphics cards. Close collaborations with amd
(which owns the ATI brand) and NVIDIA were critical for getting OpenMM to run on their GPUs.
"Cross-platform solutions like OpenMM enable a much bro...
Oak Ridge supercomputer is the world's fastest for science
...lops in 2006 and 263 teraflops in 2007. In 2008, with approximately 182,000 amd
Opteron processing cores, the new 1.64-petaflop system is more than 60 time...lops actual performance on HPL benchmark program
182,000 processing cores
quad-core OpteronTM 2.3 gigahertz processors
Genetic finding implicates innate immune system in major cause of blindness
...s of people aged 80 years or older are affected by amd
to some degree, with more than one in ten left bli...are usage are seven-times higher for patients with amd
than for those unaffected.
Researchers have pre...lear from research that this is the case. Previous amd
genes have already implicated the 'alternate' comp...
Eat oily fish at least once a week to protect your eyesight in old age
...are two types of AMD, wet and dry. Of the two, wet amd
is the main
cause of vision loss. A team of resear...atty
acids with wet AMD, comparing people with wet amd
with controls. Participants were
interviewed abou... Europeans to show a beneficial association on wet amd
consumption of oily fish and is consisten...
Roadrunner supercomputer puts research at a new scale
...available hardware, including aspects of commercial game console technologies. Roadrunner has a unique hybrid design comprised of nodes containing two amd
OpteronTM dual-core processors plus four PowerXCell 8iTM processors used as computational accelerators. The accelerators are a special IBM-developed v...
Blood vessel protein reverses macular degeneration, diabetic retinopathy in mice
... significant implications for developing drugs that activate Robo4 to treat amd
and diabetic retinopathy, said Kang Zhang, M.D., Ph.D., associate professor...ories closely collaborated on the research, using the same animal models of amd
and diabetic retinopathy that are required for drug development. The collab...
AMD in Biological Technology
Looking at AMD Through Patients' Eyes: Viscira Virtual Exhibit Educates Physicians by Personalizing Serious Eye Disease
To help eye specialists better understand the impact of one of the fastest growing eye diseases on their patients, Viscira teamed up with an industry-leading biotech company to provide physicians with a virtual experience of having neovascular (wet) age-related macular degeneration (AMD).
Alimera Sciences Begins Pilot Study to Assess Safety and Efficacy of Iluvien(TM) in Patients With Bilateral Geographic Atrophy Due to AMD
ATLANTA, Dec. 11 /PRNewswire/ -- Alimera Sciences Inc., a privately held
biopharmaceutical company that specializes in the research, development and
commercialization of prescription ophthalmic pharmaceuticals, today reported
that enrollment has begun for a pilot study to assess the safety and eff...
First European Patient Treated in CABERNET Trial With Novel Treatment for Wet AMD
Ophthalmic Clinic in Germany First in Europe To Treat Patients With New Focused Radiation Therapy
LEIPZIG, Germany, November 29 /PRNewswire/ -- NeoVista, Inc. announced
today that the first European patient has been treated in the company's
pivotal global clinical trial f...
Armstrongs new Trek modeled on AMD 64-bit processors
WATERLOO, Wis. - Coming out of the Tour de France s fourth stage Wednesday, Lance Armstrong and the U.S. Postal team are once again in the lead. That must make the designers at Trek Bicycles happy: they made the bikes the team is riding.
Founded in 1976 in Waterloo, Wisconsin, the now-interna...
Calvert Research Licenses Novel Technology to Treat Age Related Macular Degeneration from Tulane University
...lls of the central retina at the back of the eye. amd
is characterized by two types: a dry (atrophic) and wet (exudative) form. Wet amd
occurs when abnormal blood vessels behind the reti...arget and kill abnormal blood vessels found in wet amd
The lead compound from this techno...
Results From Neurotech's NT-501 Phase 2 Retinitis Pigmentosa Studies Demonstrate Consistent Biological Effect on Photoreceptors
...o initiate a Phase 1 study for our second product candidate, NT-503, in wet amd
in the second half of this year. NT-503 inhibits a well-validated target in... one-time administration for a 12 to 18 month period versus the current wet amd
treatment regimen that requires monthly injections with very close patient ...
Robust Annual Growth Through 2012 in the Age-Related Macular Degeneration Market Will Be Driven by Expanding Use of Lucentis in Europe
...eration finds that near-term opportunity in wet amd
exists in the development of therapies that offer ...cept will garner about 10 percent patient share in amd
in 2017 but its sales will fall short of blockbust...between now and 2017.
"Overall growth of the amd
market for prescription therapies is driven by age...
EyeScience Launches Comprehensive Online Resource Devoted to Age-Related Macular Degeneration Education and Prevention
...on (AMD) in a unique watch-and-learn video format. amd
is a progressive, hereditary eye disease that is t... than 20 watch-and-learn videos about eye anatomy, amd
symptoms, dry and wet macular degeneration, diagno...n where consumers can submit their questions about amd
or problems they may personally be experiencing wi...
NVIDIA CUDA Technology Dramatically Advances the Pace of Scientific Research
...r than an
average dual core consumer CPU (2.66 GHz amd
GPUGRID,... CPU and is based on an ATI Radeon HD4870 GPU, amd
Phenom 9950 CPU
(Dual Core 2.66GHz) 2GB D... CPU and is based on an ATI Radeon HD4870 GPU, amd
Phenom 9950 CPU
(Dual Core 2.66GHz) 2GB D...
Potentia Pharmaceuticals Appoints Johanna M. Seddon, M.D. and Janet Stoltz Sunness, M.D. to Scientific Advisory Board
...ing drug candidate in the treatment of
both dry and wet AMD."
is the leading cause of blindness in the elderly of the western
world and a...llion patients in the United States alone.
The current standard of care for amd
relies primarily on angiogenesis
inhibitors, an approach geared towards the...
AMD in Biological Products
Expression from Genamics
Description:...gorithms used in Expression allow virtually all computations to occur in real-time, greatly simplifying the analysis approach. The intuitive interface amd
comprehensive set of online tutorials means that Expression is easy to learn for professionals in the laboratory, as well as being readily adaptable f...
AMD in Biological Dictionary
...lon and a ... shows HSCR to be a multigenic disorder . ... But because ita multigenic disease—meaning it is caused by multiple genes that ... amd
is one of the few multigenic disorders for which a set of susceptibility ... Type 1 Diabetes is a multigenic disorder with a high prevalenc...